Screener
Pacira BioSciences, Inc. PCRX Operating Lease Liabilities (Total)
Operating Lease Liabilities (Total) at other companies
Other financials
Where this comes from
Reported directly by Pacira BioSciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.
The source filing: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:07 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-028871
FAQ
- What is Pacira BioSciences, Inc.'s operating lease liabilities (total)?
- Pacira BioSciences, Inc. (PCRX) reported operating lease liabilities (total) of $43.52M in Q1 2026.
- How has Pacira BioSciences, Inc.'s operating lease liabilities (total) changed year-over-year?
- Pacira BioSciences, Inc.'s operating lease liabilities (total) decreased by 18.0% year-over-year, from $53.08M to $43.52M.
- What is the long-term trend for Pacira BioSciences, Inc.'s operating lease liabilities (total)?
- Over 5 years (2020 to 2025), Pacira BioSciences, Inc.'s operating lease liabilities (total) has grown at a -10.1% compound annual growth rate (CAGR), from $78.45M to $46.02M.
- What does operating lease liabilities (total) mean?
- This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.
Ask your AI about Pacira BioSciences, Inc.'s operating lease liabilities (total).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude